These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8549062)

  • 1. Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft.
    Liu JJ; Chen JR; Buxton BB; Johnston CI; Burrell LM
    Clin Sci (Lond); 1995 Nov; 89(5):481-5. PubMed ID: 8549062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular responses to vasopressin antagonists in man and rat.
    Burrell LM; Phillips PA; Rolls KA; Buxton BF; Johnston CI; Liu JJ
    Clin Sci (Lond); 1994 Oct; 87(4):389-95. PubMed ID: 7834989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
    Chen YL; Shepherd C; Spinelli W; Lai FM
    Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances.
    Kostrzewska A; Laudanski T; Steinwall M; Bossmar T; Serradeil-Le Gal C; Akerlund M
    Acta Obstet Gynecol Scand; 1998 Jan; 77(1):3-7. PubMed ID: 9492709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium.
    Bossmar T; Rasmussen T; Akerlund M
    Acta Obstet Gynecol Scand; 1996 Jul; 75(6):516-9. PubMed ID: 8693925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.
    Brouard R; Laporte V; Serradeil Le Gal C; Pignol R; Jang H; Donat F; Lockwood G; Fournie D; Dreux F
    Adv Exp Med Biol; 1998; 449():455-65. PubMed ID: 10026839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
    Serradeil-Le Gal C; Bourrié B; Raufaste D; Carayon P; Garcia C; Maffrand JP; Le Fur G; Casellas P
    Biochem Pharmacol; 1994 Feb; 47(4):633-41. PubMed ID: 8129742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney.
    Barthelmebs M; Krieger JP; Grima M; Nisato D; Imbs JL
    Eur J Pharmacol; 1996 Oct; 314(3):325-32. PubMed ID: 8957254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SR 49059, a non-peptide antagonist of vasopressin V1a receptors, on vasopressin-induced coronary vasoconstriction in conscious rabbits.
    Serradeil-Le Gal C; Villanova G; Boutin M; Maffrand JP; Le Fur G
    Fundam Clin Pharmacol; 1995; 9(1):17-24. PubMed ID: 7768483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human internal mammary artery responses to non-peptide vasopressin antagonists.
    Liu JJ; Phillips PA; Burrell LM; Buxton BB; Johnston CI
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):121-4. PubMed ID: 8039263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
    Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
    Weber R; Pechère-Bertschi A; Hayoz D; Gerc V; Brouard R; Lahmy JP; Brunner HR; Burnier M
    Hypertension; 1997 Nov; 30(5):1121-7. PubMed ID: 9369265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
    Calò G; Rizzi A; Traina L; Regoli D
    Life Sci; 1997; 60(4-5):PL63-8. PubMed ID: 9010490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
    Bax WA; Van der Graaf PH; Stam WB; Bos E; Nisato D; Saxena PR
    Eur J Pharmacol; 1995 Oct; 285(2):199-202. PubMed ID: 8566139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
    Serradeil-Le Gal C; Wagnon J; Garcia C; Lacour C; Guiraudou P; Christophe B; Villanova G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1993 Jul; 92(1):224-31. PubMed ID: 8392086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones.
    Gouzènes L; Dayanithi G; Moos FC
    Neuroreport; 1999 Jun; 10(8):1735-9. PubMed ID: 10501566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin V2 (SR121463A) and V1a (SR49059) receptor antagonists both inhibit desmopressin vasorelaxing activity.
    Méchaly I; Laurent F; Portet K; Serrano J; Cros G
    Eur J Pharmacol; 1999 Nov; 383(3):287-90. PubMed ID: 10594321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions.
    Bossmar T; Brouard R; Döberl A; Akerlund M
    Br J Obstet Gynaecol; 1997 Apr; 104(4):471-7. PubMed ID: 9141585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.